Infinity Pharmaceuticals Valuation

Infinity Pharmaceuticals Inc -- USA Stock  

USD 2.28  0.12  5%

Infinity Pharmaceuticals retains regular Real Value of $1.91 per share. The prevalent price of the corporation is $2.28. Based on Macroaxis valuation methodology, the corporation appears to be over valued. Macroaxis calculates value of Infinity Pharmaceuticals from evaluating the corporation fundamentals such as Shares Owned by Insiders of 2.57%, Return On Asset of (26.58)% and Return On Equity of (78.61)% as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.

Valuation Drivers Correlation

Selected Infinity Pharmaceuticals Inc Valuation Data Over Time

Net Income Per Employee    Enterprise Value    Market Capitalization    
Investment Horizon     30 Days    Login   to change
Infinity Pharmaceuticals Inc is rated below average in price to book category among related companies. It is currently regarded as number one stock in price to earning category among related companies .
Over Valued
October 23, 2017
Market Value
Downside upside
Real Value
Target Price Odds
 Above  Below  
Upside upside
Infinity Pharmaceuticals is abnormally risky asset. Calculation of real value of Infinity Pharmaceuticals is based on 1 month time horizon. Increasing Infinity Pharmaceuticals time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.


Infinity Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
Infinity Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Infinity Pharmaceuticals Analyst Advice  

Tax Efficiency

Infinity Pharmaceuticals Tax Efficiency History

Tax Efficiency

Market Capitalization

Infinity Pharmaceuticals Market Capitalization Analysis
Infinity Pharmaceuticals Inc is rated fifth overall in market capitalization category among related companies. Market capitalization of Pharmaceutical Products industry is currently estimated at about 1.1 Billion. Infinity Pharmaceuticals retains roughly 115.57 Million in market capitalization claiming about 10% of equities listed under Pharmaceutical Products industry.
Capitalization  Revenue  Valuation  Workforce  Total debt